\-\ Texto\\:\\ \ \(0\)\
\-\ alb\\ 2\\.6\\ alk\\ phos\\ 202\\ ast\\ 572\\ alt\\ 757\\ tbili\\ 0\\.9\\ \\ amylase\\ 505\\ lipase\\ 2585\\ \\ normal\\ hepatitis\\ panel\\ and\\ cbc\ \(0\)\
\-\ patient\\ received\\ laparoscopic\\ cholecystectomy\\.\\ \\ \\ symptoms\\ improved\\ and\\ patient\\ was\\ discharged\\.\ \(0\)\
\-\ us\\:\\ \\ contracted\\ gallbladder\\ with\\ gallstones\\ suggestive\\ of\\ cholecystitis\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ mrcp\\:\\ multiple\\ gallstones\\ within\\ gallbladder\\,\\ small\\ amt\\.\\ of\\ fluid\\ around\\ gallbladder\\,\\ and\\ thickening\\ of\\ gallbladder\\ wall\\.\\ \\ no\\ evidence\\ of\\ intrahepatic\\ or\\ extrahepatic\\ ductal\\ dilatations\\ or\\ of\\ luminal\\ stone\\ within\\ the\\ common\\ bile\\ duct\ \(0\)\
\-\ cholecystitis\ \(124\)\
\-\ cholecystitis\\,\\ choledocholithiasis\\,\\ cholangitis\\,\\ acute\\ pancreatitis\ \(1\)\
\-\ 24\\ y\\/o\\ female\\ patient\\ with\\ history\\ of\\ abdominal\\ pain\\ and\\ recurrent\\ pancreatitis\\ presents\\ with\\ hepatic\\ panel\\ lab\\ values\\ suggestive\\ of\\ obstructive\\ pattern\\.\ \(1\)\
\-\ acute\\ cholecystitis\\ typically\\ presents\\ with\\ right\\ upper\\ quadrant\\ or\\ periumbilical\\ abdominal\\ pain\\ that\\ may\\ radiate\\ to\\ the\\ back\\ or\\ shoulder\\,\\ fever\\,\\ and\\ leukocytosis\\.\\ \\ the\\ gallbladder\\ becomes\\ inflamed\\ due\\ to\\ blockage\\ of\\ the\\ cystic\\ duct\\-\\-not\\ all\\ gallstones\\ produce\\ enough\\ irritation\\ to\\ produce\\ inflammation\\.\\ \\ many\\ people\\ with\\ gallstones\\ are\\ asymptomatic\\,\\ some\\ have\\ episodes\\ of\\ biliary\\ colic\\,\\ and\\ others\\ develop\\ cholecystitis\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ the\\ diagnosis\\ is\\ most\\ commonly\\ made\\ via\\ ultrasound\\,\\ which\\ may\\ show\\ presence\\ of\\ gallstones\\,\\ gallbladder\\ wall\\ thickening\\,\\ and\\/or\\ pericholic\\ fluid\\.\\ \\ studies\\ have\\ shown\\ that\\ us\\ is\\ fairly\\ sensitive\\ in\\ \\>80\\%\\ of\\ cases\\.\\ \\ one\\ study\\ reported\\ by\\ m\\.t\\.\\ keogan\\ suggested\\ that\\ mrcp\\ with\\ half\\-fourier\\ rare\\ sequence\\ has\\ a\\ sensitivity\\ of\\ 91\\%\\ and\\ specificity\\ of\\ 79\\%\\ for\\ acute\\ cholecystitis\\ though\\ other\\ studies\\ suggest\\ lower\\ sensitivity\\ \\(70\\%\\)\\.\\ \\ for\\ detection\\ of\\ stones\\ in\\ the\\ cystic\\ duct\\,\\ however\\,\\ mrcp\\ is\\ indisputably\\ more\\ reliable\\ than\\ ultrasound\\;\\ with\\ reported\\ sensitivity\\ and\\ specificity\\ of\\ 95\\ and\\ 97\\ percent\\.\\ \\ ercp\\ has\\,\\ in\\ the\\ past\\,\\ been\\ commonly\\ used\\ for\\ visualization\\ of\\ the\\ ductal\\ system\\ and\\ is\\ useful\\ for\\ concurrent\\ stone\\ extraction\\,\\ stent\\ insertion\\,\\ or\\ biopsy\\.\\ \\ but\\ mrcp\\ has\\ become\\ useful\\ because\\ it\\ is\\ less\\ invasive\\ and\\ does\\ not\\ require\\ addition\\ of\\ contrast\\-\\-hence\\ decreasing\\ procedure\\ morbidity\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ left\\ untreated\\,\\ cholecystitis\\ may\\ resolve\\.\\ \\ but\\ due\\ to\\ the\\ various\\ complications\\ which\\ can\\ occur\\ such\\ as\\ gallbladder\\ gangrene\\,\\ perforated\\ gallbladder\\,\\ or\\ cholecystoenteric\\ fistula\\ leading\\ to\\ gallstone\\ ileus\\,\\ removal\\ of\\ the\\ gallbladder\\ is\\ the\\ preferred\\ method\\ of\\ treatment\\ and\\ is\\ commonly\\ performed\\ via\\ laparoscopic\\ method\\ converted\\ to\\ open\\ cholecystectomy\\ as\\ needed\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gallbladder\\:\\ 0\\.09355416203515818\ \(0\)\
\-\ cholecystitis\\:\\ 0\\.08043535730291924\ \(0\)\
\-\ gallstones\\:\\ 0\\.06588101913066169\ \(0\)\
\-\ mrcp\\:\\ 0\\.06329690193929075\ \(0\)\
\-\ sensitivity\\:\\ 0\\.03665722311951056\ \(0\)\
\-\ duct\\:\\ 0\\.02975452119505509\ \(0\)\
\-\ specificity\\:\\ 0\\.028138844992126662\ \(0\)\
\-\ laparoscopic\\:\\ 0\\.026931700569620343\ \(0\)\
\-\ method\\:\\ 0\\.026931700569620343\ \(0\)\
\-\ panel\\:\\ 0\\.025475082481256895\ \(0\)\
\-\ commonly\\:\\ 0\\.024490112228777023\ \(0\)\
\-\ produce\\:\\ 0\\.02398977711423179\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.023738653361627376\ \(0\)\
\-\ cholecystectomy\\:\\ 0\\.023124168009707034\ \(0\)\
\-\ useful\\:\\ 0\\.022576251125452692\ \(0\)\
\-\ 572\\:\\ 0\\.0223177681619405\ \(0\)\
\-\ 757\\:\\ 0\\.0223177681619405\ \(0\)\
\-\ 2585\\:\\ 0\\.0223177681619405\ \(0\)\
\-\ m\\.t\\:\\ 0\\.0223177681619405\ \(0\)\
\-\ keogan\\:\\ 0\\.0223177681619405\ \(0\)\
\-\ half\\-fourier\\:\\ 0\\.0223177681619405\ \(0\)\
\-\ indisputably\\:\\ 0\\.0223177681619405\ \(0\)\
\-\ cholecystoenteric\\:\\ 0\\.0223177681619405\ \(0\)\
\-\ stone\\:\\ 0\\.02152491256961348\ \(0\)\
\-\ 505\\:\\ 0\\.020562965173181146\ \(0\)\
\-\ pericholic\\:\\ 0\\.020562965173181146\ \(0\)\
\-\ ductal\\:\\ 0\\.020395071803465583\ \(0\)\
\-\ \\%\\:\\ 0\\.02018552945160514\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.019874274915163265\ \(0\)\
\-\ 202\\:\\ 0\\.019536471228603514\ \(0\)\
\-\ amt\\:\\ 0\\.019536471228603514\ \(0\)\
\-\ dilatations\\:\\ 0\\.019536471228603514\ \(0\)\
\-\ via\\:\\ 0\\.018572273150142\ \(0\)\
\-\ suggestive\\:\\ 0\\.01848472126604043\ \(0\)\
\-\ us\\:\\ 0\\.018148910415756513\ \(0\)\
\-\ converted\\:\\ 0\\.01739141335420553\ \(0\)\
\-\ contracted\\:\\ 0\\.017053359195662435\ \(0\)\
\-\ gangrene\\:\\ 0\\.017053359195662435\ \(0\)\
\-\ reliable\\:\\ 0\\.016755174295266528\ \(0\)\
\-\ colic\\:\\ 0\\.01624714721814716\ \(0\)\
\-\ studies\\:\\ 0\\.016159498317869163\ \(0\)\
\-\ alb\\:\\ 0\\.016026865251084804\ \(0\)\
\-\ acute\\:\\ 0\\.01602439996789743\ \(0\)\
\-\ 0\\.9\\:\\ 0\\.015824225484822686\ \(0\)\
\-\ radiate\\:\\ 0\\.015824225484822686\ \(0\)\
\-\ reported\\:\\ 0\\.015772530888991453\ \(0\)\
\-\ blockage\\:\\ 0\\.015636610365446175\ \(0\)\
\-\ extraction\\:\\ 0\\.015461944868010856\ \(0\)\
\-\ or\\:\\ 0\\.015213003781727203\ \(0\)\
\-\ 97\\:\\ 0\\.015145076151671601\ \(0\)\
\-\ \\,\\:\\ 0\\.015077522636405879\ \(0\)\
\-\ choledocholithiasis\\:\\ 0\\.015000371306507174\ \(0\)\
\-\ inflamed\\:\\ 0\\.015000371306507174\ \(0\)\
\-\ concurrent\\:\\ 0\\.015000371306507174\ \(0\)\
\-\ 91\\:\\ 0\\.014863492265316603\ \(0\)\
\-\ periumbilical\\:\\ 0\\.014733635823829132\ \(0\)\
\-\ thickening\\:\\ 0\\.014666453517434692\ \(0\)\
\-\ tbili\\:\\ 0\\.014610116420868544\ \(0\)\
\-\ irritation\\:\\ 0\\.014610116420868544\ \(0\)\
\-\ ercp\\:\\ 0\\.014492344229387803\ \(0\)\
\-\ luminal\\:\\ 0\\.014379808121613541\ \(0\)\
\-\ people\\:\\ 0\\.014379808121613541\ \(0\)\
\-\ gallstone\\:\\ 0\\.014379808121613541\ \(0\)\
\-\ 2\\.6\\:\\ 0\\.014272062262325448\ \(0\)\
\-\ extrahepatic\\:\\ 0\\.014272062262325448\ \(0\)\
\-\ cholangitis\\:\\ 0\\.014272062262325448\ \(0\)\
\-\ untreated\\:\\ 0\\.014272062262325448\ \(0\)\
\-\ may\\:\\ 0\\.014235405333403471\ \(0\)\
\-\ hence\\:\\ 0\\.014168715440755182\ \(0\)\
\-\ 79\\:\\ 0\\.013792968592354491\ \(0\)\
\-\ decreasing\\:\\ 0\\.013792968592354491\ \(0\)\
\-\ perforated\\:\\ 0\\.013465850284810172\ \(0\)\
\-\ amylase\\:\\ 0\\.013316886993612873\ \(0\)\
\-\ leukocytosis\\:\\ 0\\.013316886993612873\ \(0\)\
\-\ ileus\\:\\ 0\\.013316886993612873\ \(0\)\
\-\ lipase\\:\\ 0\\.013245568317747819\ \(0\)\
\-\ morbidity\\:\\ 0\\.013176203826132339\ \(0\)\
\-\ enough\\:\\ 0\\.012916319891803014\ \(0\)\
\-\ preferred\\:\\ 0\\.012855313432109189\ \(0\)\
\-\ ultrasound\\:\\ 0\\.012836063721550902\ \(0\)\
\-\ resolve\\:\\ 0\\.01279574255258971\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.012737541240628448\ \(0\)\
\-\ others\\:\\ 0\\.012737541240628448\ \(0\)\
\-\ fairly\\:\\ 0\\.012680647934673871\ \(0\)\
\-\ alk\\:\\ 0\\.012625005132854186\ \(0\)\
\-\ phos\\:\\ 0\\.012625005132854186\ \(0\)\
\-\ detection\\:\\ 0\\.01257055904368719\ \(0\)\
\-\ wall\\:\\ 0\\.01253245124171517\ \(0\)\
\-\ cystic\\:\\ 0\\.012479152948110169\ \(0\)\
\-\ hepatitis\\:\\ 0\\.012413912451995827\ \(0\)\
\-\ fluid\\:\\ 0\\.012296906858753688\ \(0\)\
\-\ sequence\\:\\ 0\\.012266396228897157\ \(0\)\
\-\ has\\:\\ 0\\.012187594712614769\ \(0\)\
\-\ 95\\:\\ 0\\.0121726208575545\ \(0\)\
\-\ stent\\:\\ 0\\.0121726208575545\ \(0\)\
\-\ various\\:\\ 0\\.011952338890492147\ \(0\)\
\-\ percent\\:\\ 0\\.01178895022938437\ \(0\)\
\-\ ast\\:\\ 0\\.011749699124230028\ \(0\)\
\-\ alt\\:\\ 0\\.011749699124230028\ \(0\)\
\-\ sensitive\\:\\ 0\\.011749699124230028\ \(0\)\
\-\ insertion\\:\\ 0\\.011711047296050816\ \(0\)\
\-\ bile\\:\\ 0\\.011562084004853517\ \(0\)\
\-\ due\\:\\ 0\\.011545707103558681\ \(0\)\
\-\ visualization\\:\\ 0\\.011421400837372983\ \(0\)\
\-\ becomes\\:\\ 0\\.011320792410412188\ \(0\)\
\-\ that\\:\\ 0\\.011209980216902456\ \(0\)\
\-\ obstructive\\:\\ 0\\.011130829914354178\ \(0\)\
\-\ stones\\:\\ 0\\.011130829914354178\ \(0\)\
\-\ suggested\\:\\ 0\\.011011671659017506\ \(0\)\
\-\ biliary\\:\\ 0\\.010925844945914516\ \(0\)\
\-\ invasive\\:\\ 0\\.01087020214409483\ \(0\)\
\-\ values\\:\\ 0\\.010815756054927834\ \(0\)\
\-\ abdominal\\:\\ 0\\.010814780952517039\ \(0\)\
\-\ develop\\:\\ 0\\.010788965904723943\ \(0\)\
\-\ episodes\\:\\ 0\\.010684553351473187\ \(0\)\
\-\ fistula\\:\\ 0\\.010608976229575257\ \(0\)\
\-\ lab\\:\\ 0\\.010584277052498385\ \(0\)\
\-\ 70\\:\\ 0\\.010394906892795354\ \(0\)\
\-\ leading\\:\\ 0\\.010349697734820652\ \(0\)\
\-\ improved\\:\\ 0\\.010305281761020881\ \(0\)\
\-\ become\\:\\ 0\\.010305281761020881\ \(0\)\
\-\ 80\\:\\ 0\\.010176526274353816\ \(0\)\
\-\ received\\:\\ 0\\.010054003386095968\ \(0\)\
\-\ though\\:\\ 0\\.010034147240625015\ \(0\)\
\-\ is\\:\\ 0\\.0099646467055521\ \(0\)\
\-\ discharged\\:\\ 0\\.00991817373168503\ \(0\)\
\-\ require\\:\\ 0\\.009899351001336883\ \(0\)\
\-\ cbc\\:\\ 0\\.009666597848613628\ \(0\)\
\-\ open\\:\\ 0\\.009615793891522971\ \(0\)\
\-\ needed\\:\\ 0\\.009422198033315787\ \(0\)\
\-\ have\\:\\ 0\\.0093693067258992\ \(0\)\
\-\ but\\:\\ 0\\.009227864815359685\ \(0\)\
\-\ suggest\\:\\ 0\\.009213591623778909\ \(0\)\
\-\ inflammation\\:\\ 0\\.009199328794112439\ \(0\)\
\-\ addition\\:\\ 0\\.00917104195715516\ \(0\)\
\-\ and\\/or\\:\\ 0\\.00914306768832836\ \(0\)\
\-\ recurrent\\:\\ 0\\.009129195623101462\ \(0\)\
\-\ procedure\\:\\ 0\\.009060953066168479\ \(0\)\
\-\ hepatic\\:\\ 0\\.009034162915964587\ \(0\)\
\-\ around\\:\\ 0\\.009007653296047384\ \(0\)\
\-\ many\\:\\ 0\\.0088916797871074\ \(0\)\
\-\ presents\\:\\ 0\\.008838705293711018\ \(0\)\
\-\ shoulder\\:\\ 0\\.008721216191997052\ \(0\)\
\-\ shown\\:\\ 0\\.008674548592784803\ \(0\)\
\-\ made\\:\\ 0\\.008617398410408756\ \(0\)\
\-\ complications\\:\\ 0\\.008572589354460905\ \(0\)\
\-\ removal\\:\\ 0\\.008528559626076425\ \(0\)\
\-\ system\\:\\ 0\\.00851767081114126\ \(0\)\
\-\ 24\\:\\ 0\\.00841128349525557\ \(0\)\
\-\ rare\\:\\ 0\\.008400886578919737\ \(0\)\
\-\ used\\:\\ 0\\.008299200397336613\ \(0\)\
\-\ pattern\\:\\ 0\\.00826947427612982\ \(0\)\
\-\ within\\:\\ 0\\.008253829915878894\ \(0\)\
\-\ occur\\:\\ 0\\.008116573743750731\ \(0\)\
\-\ which\\:\\ 0\\.008076681454392652\ \(0\)\
\-\ presence\\:\\ 0\\.007852621818878807\ \(0\)\
\-\ biopsy\\:\\ 0\\.007675172763637369\ \(0\)\
\-\ typically\\:\\ 0\\.007636520935458158\ \(0\)\
\-\ quadrant\\:\\ 0\\.0076136099594583655\ \(0\)\
\-\ because\\:\\ 0\\.007568400801483666\ \(0\)\
\-\ for\\:\\ 0\\.007383373657141419\ \(0\)\
\-\ does\\:\\ 0\\.00738131916552913\ \(0\)\
\-\ less\\:\\ 0\\.007326430390690335\ \(0\)\
\-\ fever\\:\\ 0\\.007319652219118901\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.0073128921468255375\ \(0\)\
\-\ cases\\:\\ 0\\.00720711611134464\ \(0\)\
\-\ \\>\\:\\ 0\\.007187765859920417\ \(0\)\
\-\ back\\:\\ 0\\.007136876798348043\ \(0\)\
\-\ study\\:\\ 0\\.007118054067999897\ \(0\)\
\-\ past\\:\\ 0\\.006873922713788441\ \(0\)\
\-\ such\\:\\ 0\\.006762867822381904\ \(0\)\
\-\ show\\:\\ 0\\.0066409010999788\ \(0\)\
\-\ some\\:\\ 0\\.0065694386173842005\ \(0\)\
\-\ as\\:\\ 0\\.006544696232375331\ \(0\)\
\-\ patient\\:\\ 0\\.006505761500630794\ \(0\)\
\-\ to\\:\\ 0\\.006487110507994728\ \(0\)\
\-\ not\\:\\ 0\\.006252246439199673\ \(0\)\
\-\ all\\:\\ 0\\.00611879364412985\ \(0\)\
\-\ performed\\:\\ 0\\.006031843876524858\ \(0\)\
\-\ however\\:\\ 0\\.00602371659644828\ \(0\)\
\-\ y\\/o\\:\\ 0\\.005991465898277572\ \(0\)\
\-\ been\\:\\ 0\\.00588555668218732\ \(0\)\
\-\ one\\:\\ 0\\.005862611096988973\ \(0\)\
\-\ \\:\\:\\ 0\\.005722910460712228\ \(0\)\
\-\ evidence\\:\\ 0\\.005672006540169311\ \(0\)\
\-\ than\\:\\ 0\\.005668478113717149\ \(0\)\
\-\ common\\:\\ 0\\.005661435979636449\ \(0\)\
\-\ of\\:\\ 0\\.005603980291548811\ \(0\)\
\-\ and\\:\\ 0\\.005468628022244611\ \(0\)\
\-\ more\\:\\ 0\\.0054105729349675094\ \(0\)\
\-\ symptoms\\:\\ 0\\.005391537916197821\ \(0\)\
\-\ pain\\:\\ 0\\.0052840919874973915\ \(0\)\
\-\ upper\\:\\ 0\\.005220456975617008\ \(0\)\
\-\ \\;\\:\\ 0\\.0051276485783609965\ \(0\)\
\-\ most\\:\\ 0\\.004994519346147028\ \(0\)\
\-\ other\\:\\ 0\\.0049864267055758195\ \(0\)\
\-\ small\\:\\ 0\\.004983734897167389\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0049676438753934685\ \(0\)\
\-\ can\\:\\ 0\\.004906892031567265\ \(0\)\
\-\ lower\\:\\ 0\\.004865473593326235\ \(0\)\
\-\ it\\:\\ 0\\.004862907302615232\ \(0\)\
\-\ contrast\\:\\ 0\\.004842470093184571\ \(0\)\
\-\ multiple\\:\\ 0\\.004556470894884225\ \(0\)\
\-\ female\\:\\ 0\\.004447494358095781\ \(0\)\
\-\ treatment\\:\\ 0\\.004378777112913638\ \(0\)\
\-\ the\\:\\ 0\\.003849980080354136\ \(0\)\
\-\ by\\:\\ 0\\.0036022048183414553\ \(0\)\
\-\ normal\\:\\ 0\\.0033914239356939266\ \(0\)\
\-\ in\\:\\ 0\\.0032004852922044675\ \(0\)\
\-\ history\\:\\ 0\\.002987884905587553\ \(0\)\
\-\ are\\:\\ 0\\.002949047778555954\ \(0\)\
\-\ was\\:\\ 0\\.0025019684106675614\ \(0\)\
\-\ left\\:\\ 0\\.0024205196690453537\ \(0\)\
\-\ right\\:\\ 0\\.0022826119217985233\ \(0\)\
\-\ no\\:\\ 0\\.002178339622034942\ \(0\)\
\-\ with\\:\\ 0\\.002073491728175261\ \(0\)\
\-\ \\(\\:\\ 0\\.0018287638639085076\ \(0\)\
\-\ \\)\\:\\ 0\\.001806424536995709\ \(0\)\
\-\ \\.\\:\\ 0\\.0015278281358351562\ \(0\)\
\-\ a\\:\\ 0\\.0010040501311863325\ \(0\)\
